As of 4:00pm ET
| +0.05 / +0.29%|
The 4 analysts offering 12-month price forecasts for Vanda Pharmaceuticals Inc have a median target of 22.50, with a high estimate of 27.00 and a low estimate of 20.00. The median estimate represents a +30.43% increase from the last price of 17.25.
The current consensus among 4 polled investment analysts is to Buy stock in Vanda Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.